Cargando…

Neuroligin-1 is altered in the hippocampus of Alzheimer’s disease patients and mouse models, and modulates the toxicity of amyloid-beta oligomers

Synapse loss occurs early and correlates with cognitive decline in Alzheimer’s disease (AD). Synaptotoxicity is driven, at least in part, by amyloid-beta oligomers (Aβo), but the exact synaptic components targeted by Aβo remain to be identified. We here tested the hypotheses that the post-synaptic p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dufort-Gervais, Julien, Provost, Chloé, Charbonneau, Laurence, Norris, Christopher M., Calon, Frédéric, Mongrain, Valérie, Brouillette, Jonathan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7181681/ https://www.ncbi.nlm.nih.gov/pubmed/32332783 http://dx.doi.org/10.1038/s41598-020-63255-6

Ejemplares similares

Hippocampal injections of soluble amyloid-beta oligomers alter electroencephalographic activity during wake and slow-wave sleep in rats
por: Hector, Audrey, et al.
Publicado: (2023)

Neurodegeneration in an Animal Model of Chronic Amyloid-beta Oligomer Infusion Is Counteracted by Antibody Treatment Infused with Osmotic Pumps
por: Sajadi, Ahmadali, et al.
Publicado: (2016)

The effect of Neuroligin-2 absence on sleep architecture and electroencephalographic activity in mice
por: Seok, Bong Soo, et al.
Publicado: (2018)

Correction to: The effect of Neuroligin-2 absence on sleep architecture and electroencephalographic activity in mice
por: Seok, Bong Soo, et al.
Publicado: (2019)

The Toxicity of Amyloid β Oligomers
por: Zhao, Li Na, et al.
Publicado: (2012)

The Role of α-sheet in Amyloid Oligomer Aggregation and Toxicity
por: Bi, Timothy M., et al.
Publicado: (2018)

Immunogenic properties of amyloid beta oligomers
por: Dalgediene, Indre, et al.
Publicado: (2013)

Alzheimer’s disease pathology propagation by exosomes containing toxic amyloid-beta oligomers
por: Sardar Sinha, Maitrayee, et al.
Publicado: (2018)

The Toxicity and Polymorphism of β-Amyloid Oligomers
por: Huang, Ya-ru, et al.
Publicado: (2020)

Hyperactivity Induced by Soluble Amyloid-β Oligomers in the Early Stages of Alzheimer's Disease
por: Hector, Audrey, et al.
Publicado: (2021)

Probing pathways by which rhynchophylline modifies sleep using spatial transcriptomics
por: Ballester Roig, Maria Neus, et al.
Publicado: (2023)

Shared amyloid oligomer structure proves toxic
por: Tuma, Rabiya S.
Publicado: (2003)

Sleep is bi-directionally modified by amyloid beta oligomers
por: Özcan, Güliz Gürel, et al.
Publicado: (2020)

Correction: A glycine zipper motif mediates the formation of toxic beta-amyloid oligomers in vitro and in vivo
por: Fonte, Virginia, et al.
Publicado: (2014)

Structural Optimization of Foldamer-Dendrimer Conjugates as Multivalent Agents against the Toxic Effects of Amyloid Beta Oligomers
por: Bartus, Éva, et al.
Publicado: (2018)

Toxic species in amyloid disorders: Oligomers or mature fibrils
por: Verma, Meenakshi, et al.
Publicado: (2015)

The Role of Amyloid-β Oligomers in Toxicity, Propagation, and Immunotherapy
por: Sengupta, Urmi, et al.
Publicado: (2016)

Origin, toxicity and characteristics of two amyloid oligomer polymorphs
por: Niyangoda, Chamani, et al.
Publicado: (2021)

Application of an Amyloid Beta Oligomer Standard in the sFIDA Assay
por: Kühbach, Katja, et al.
Publicado: (2016)

Synaptic dysregulation and hyperexcitability induced by intracellular amyloid beta oligomers
por: Fernandez‐Perez, Eduardo J., et al.
Publicado: (2021)

Editorial: Beta-Amyloid oligomer specific treatments for Alzheimer's disease
por: Hillen, Heinz
Publicado: (2023)

Keampferol-3-O-rhamnoside abrogates amyloid beta toxicity by modulating monomers and remodeling oligomers and fibrils to non-toxic aggregates
por: Sharoar, Md Golam, et al.
Publicado: (2012)

Designed α-sheet peptides inhibit amyloid formation by targeting toxic oligomers
por: Hopping, Gene, et al.
Publicado: (2014)

Plasma amyloid-beta oligomer is related to subjective cognitive decline and brain amyloid status
por: Kim, Keun You, et al.
Publicado: (2022)

Alzheimer’s Toxic Amyloid Beta Oligomers: Unwelcome Visitors to the Na/K ATPase alpha3 Docking Station
por: DiChiara, Thomas, et al.
Publicado: (2017)

Roles of neuroligins in central nervous system development: focus on glial neuroligins and neuron neuroligins
por: Liu, Xing, et al.
Publicado: (2022)

The culprit behind amyloid beta peptide related neurotoxicity in Alzheimer's disease: oligomer size or conformation?
por: Broersen, Kerensa, et al.
Publicado: (2010)

Serpins show structural basis for oligomer toxicity and amyloid ubiquity
por: Carrell, Robin W., et al.
Publicado: (2008)

Editorial: Oligomers in amyloid-associated diseases—structural properties and toxicity
por: Vassallo, Neville, et al.
Publicado: (2023)

Beta amyloid oligomers and fibrils stimulate differential activation of primary microglia
por: Sondag, Cindy M, et al.
Publicado: (2009)

Quantitative analysis of co-oligomer formation by amyloid-beta peptide isoforms
por: Iljina, Marija, et al.
Publicado: (2016)

Near infrared light decreases synaptic vulnerability to amyloid beta oligomers
por: Comerota, Michele M., et al.
Publicado: (2017)

Corrigendum: Synaptic dysregulation and hyperexcitability induced by intracellular amyloid beta oligomers
Publicado: (2021)

A case report of severe tuberous sclerosis complex detected in utero and linked to a novel duplication in the TSC2 gene
por: Mongrain, Valérie, et al.
Publicado: (2020)

A hydrogel biosensor for high selective and sensitive detection of amyloid-beta oligomers
por: Sun, Liping, et al.
Publicado: (2018)

Heptameric Peptide Interferes with Amyloid-β Aggregation by Structural Reorganization of the Toxic Oligomers
por: Bhattacharyya, Rajanya, et al.
Publicado: (2020)

An Aged Canid with Behavioral Deficits Exhibits Blood and Cerebrospinal Fluid Amyloid Beta Oligomers
por: Rusbridge, Clare, et al.
Publicado: (2018)

A Rationally Designed Humanized Antibody Selective for Amyloid Beta Oligomers in Alzheimer’s Disease
por: Gibbs, Ebrima, et al.
Publicado: (2019)

Amyloid Beta Oligomers Target to Extracellular and Intracellular Neuronal Synaptic Proteins in Alzheimer's Disease
por: Ding, Yu, et al.
Publicado: (2019)

Role of Lipocalin-2 in Amyloid-Beta Oligomer-Induced Mouse Model of Alzheimer’s Disease
por: Kang, Heeyoung, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_26hjokd0h914ln4jkphc97nlbn